Craig Tooman
Chief Financial Officer
CFO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Silence Therapeutics plc (SLN) | Former Chief Executive Officer | $690,687 | $2,246,863 |
| 2024 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $618,844 | $3,693,970 |
| 2023 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $589,375 | $9,099,969 |
| 2022 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $557,118 | $6,039,265 |
Executive changes
- 2025-12-14
-
Resigned President, Chief Executive Officer and a member of the Company's Board of Directors at Silence Therapeutics plc (SLN)2025-12-14
Earnings-call appearances
-
Silence Therapeutics plc Q4 FY2024 Earnings Call2025-02-27
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2023 Earnings Call2023-12-31
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2022 Earnings Call2022-12-31
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2021 Earnings Call2021-12-31
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q2 FY2021 Earnings Call2021-08-12
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2020 Earnings Call2020-12-31
Silence Therapeutics plc (SLN)